The ‘Pain Management Panel’ test from GeneTrait Laboratories analyzes your DNA to assess your likely reaction to common pain management medications and your risk for related conditions.
You’ll receive a report that provides information about how your DNA affects your response to pain management treatments and risk of developing hyperhomocysteinemia. Results will cover the following medications: